Overview
Ventilator-associated pneumonia (VAP) is a common nosocomial infection occurring in mechanically ventilated patients, characterized by the development of pneumonia 48 hours or longer after initiation of mechanical ventilation 1.Diagnosis
Clinical signs including fever, leukocytosis, purulent tracheal secretions, and changes in breath sounds 1.
Diagnostic tests: Chest X-ray showing infiltrates, sputum culture, and blood cultures to identify pathogens 1.
Bronchoscopy with bronchoalveolar lavage may be used for definitive diagnosis in complex cases 1.Management
First-line treatments: Broad-spectrum antibiotics tailored to local resistance patterns, typically initiated empirically 1.
Adjunctive treatments:
- Early mobilization and physiotherapy to reduce aspiration risk 1.
- Use of subglottic secretion drainage devices to decrease colonization of the airways 1.
- Consideration of selective digestive decontamination (SDD) in specific settings, though evidence varies 1.Special Populations
Pediatrics: Manual chest compression-vibrations during physiotherapy may enhance airway clearance in sedated, fully ventilated children, potentially reducing VAP risk 1.Key Recommendations
Implement early mobilization and physiotherapy techniques, including chest compression-vibrations, to decrease VAP incidence in ventilated pediatric patients (Evidence: Moderate) 1.
Tailor empirical antibiotic therapy based on local resistance patterns to optimize treatment efficacy (Evidence: Strong) 1.
Utilize subglottic secretion drainage devices to mitigate the risk of VAP in mechanically ventilated patients (Evidence: Moderate) 1.References
1 Gregson RK, Shannon H, Stocks J, Cole TJ, Peters MJ, Main E. The unique contribution of manual chest compression-vibrations to airflow during physiotherapy in sedated, fully ventilated children. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2012. link